Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis.
continuous glucose monitoring
randomized trial
systematic review
type 1 diabetes
type 2 diabetes
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
11
01
2023
received:
04
12
2022
accepted:
17
01
2023
medline:
4
4
2023
pubmed:
21
1
2023
entrez:
20
1
2023
Statut:
ppublish
Résumé
To evaluate the effect on glucose control of professional continuous glucose monitoring (p-CGM)-based care as compared with standard care in the management of patients with type 1 and type 2 diabetes. The PubMed database was searched comprehensively to identify prospective or retrospective studies evaluating p-CGM as a diagnostic tool for subsequent implementation of lifestyle and/or medication changes and reporting glycated haemoglobin (HbA1c) as an outcome measure. We found 872 articles, 22 of which were included in the meta-analysis. Overall, the use of p-CGM was associated with greater HbA1c reduction from baseline (-0.28%, 95% confidence interval [CI] -0.36% to -0.21%, I In patients with type 1 and type 2 diabetes, p-CGM-driven care is superior to usual care in improving glucose control without increasing hypoglycaemia.
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1301-1310Informations de copyright
© 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Di Molfetta S, Rossi A, Assaloni R, et al. A guide for the use of LibreView digital diabetes platform in clinical practice: expert paper of the Italian working group on diabetes and technology. Diabetes Res Clin Pract. 2022;187:109867. doi:10.1016/j.diabres.2022.109867
Castellana M, Parisi C, Di Molfetta S, et al. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2020;8(1):e001092. doi:10.1136/bmjdrc-2019-001092
Gavin JR, Bailey CJ. Real-world studies support use of continuous glucose monitoring in type 1 and type 2 diabetes independently of treatment regimen. Diabetes Technol Ther. 2021;23(S3):S19-S27. doi:10.1089/dia.2021.0211
DiMeglio LA, Acerini CL, Codner E, et al. ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):105-114. doi:10.1111/pedi.12737
Holt RIG, DeVries JH, Hess-Fischl A, et al. The Management of Type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. doi:10.2337/dci21-0043
Blevins TC. Professional continuous glucose monitoring in clinical practice 2010. J Diabetes Sci Technol. 2010;4(2):440-456. doi:10.1177/193229681000400226
Miller EM. Using continuous glucose monitoring in clinical practice. Clin Diabetes. 2020;38(5):429-438. doi:10.2337/cd20-0043
Adkison JD, Chung PE. Implementing continuous glucose monitoring in clinical practice. Fam Pract Manag. 2021;28(2):7-14.
Meng R, Gu T, Yang F, Liu J, Sun Q, Zhu D. Performance evaluation of the Glunovo® continuous blood glucose monitoring system in Chinese participants with diabetes: a multicenter, self-controlled trial. Diabetes Ther. 2021;12(12):3153-3165. doi:10.1007/s13300-021-01171-2
Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193. doi:10.2337/ds18-0093
Rivera-Ávila DA, Esquivel-Lu AI, Salazar-Lozano CR, Jones K, Doubova SV. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes. BMC Endocr Disord. 2021;21(1):79. doi:10.1186/s12902-021-00742-5
Associazione Medici Diabetologi SIdD, Società Italiana di Endocrinologia e Diabetologia Pediatrica. Documento del Gruppo di Studio Intersocietario AMD - SID - SIEDP “Tecnologia e diabete”. 2019.
Grunberger G, Sherr J, Allende M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: the use of advanced Technology in the Management of persons with diabetes mellitus. Endocr Pract. 2021;27(6):505-537. doi:10.1016/j.eprac.2021.04.008
Golicki DT, Golicka D, Groele L, Pankowska E. Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2008;51(2):233-240. doi:10.1007/s00125-007-0884-9
Ida S, Kaneko R, Murata K. Utility of real-time and retrospective continuous glucose monitoring in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. J Diabetes Res. 2019;2019:4684815-4684810. doi:10.1155/2019/4684815
Ribeiro RT, Andrade R. Nascimento do Ó D, lopes AF, Raposo JF. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy. Nutr Metab Cardiovasc Dis. 2021;31(4):1267-1275. doi:10.1016/j.numecd.2020.12.024
Furler J, O'Neal D, Speight J, et al. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(1):17-26. doi:10.1016/S2213-8587(19)30385-7
Olsen U, Lindberg MF, Rose C, et al. Factors correlated with physical function 1 year after Total knee arthroplasty in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7):e2219636. doi:10.1001/jamanetworkopen.2022.19636
Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis. Diabetes Care. 2017;40(11):1588-1596. doi:10.2337/dc16-1925
Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. Evid Based Ment Health. 2020;23:83-87.
Verde PE, Ohmann C. Combining randomized and non-randomized evidence in clinical research: a review of methods and applications. Res Synth Methods. 2015;6(1):45-62. doi:10.1002/jrsm.1122
Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, Attali JR, Pariès J, Schaepelynck-Bélicar P. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab. 2009;35(4):312-318. doi:10.1016/j.diabet.2009.02.006
Anjana RM, Kesavadev J, Neeta D, et al. A multicenter real-life study on the effect of flash glucose monitoring on glycemic control in patients with type 1 and type 2 diabetes. Diabetes Technol Ther. 2017;19(9):533-540.
Tanenberg R, Bode B, Lane W, et al. Use of the continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc. 2004;79(12):1521-1526. doi:10.4065/79.12.1521
Ajjan RA, Jackson N, Thomson SA. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial. Diab Vasc Dis Res. 2019;16(4):385-395. doi:10.1177/1479164119827456
Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2008;80(3):371-379. doi:10.1016/j.diabres.2008.01.006
Blackberry ID, Furler JS, Ginnivan LE, et al. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study. Diabetes Res Clin Pract. 2014;106(2):247-255. doi:10.1016/j.diabres.2014.08.011
Fantasia KL, Stockman MC, Ju Z, et al. Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: results of a clinical pilot program. J Clin Transl Endocrinol. 2021;24:100254. doi:10.1016/j.jcte.2021.100254
Kesavadev J, Vigersky R, Shin J, et al. Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: a retrospective evaluation. Adv Ther. 2017;34(8):1918-1927. doi:10.1007/s12325-017-0576-x
Kim SK, Kim HJ, Kim T, et al. Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice. Diabetes Metab J. 2014;38(6):449-455. doi:10.4093/dmj.2014.38.6.449
Sato J, Kanazawa A, Ikeda F, et al. Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: a randomized controlled trial. J Int Med Res. 2016;44(1):109-121. doi:10.1177/0300060515600190
Sierra JA, Shah M, Gill MS, et al. Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data. J Med Econ. 2018;21(3):225-230. doi:10.1080/13696998.2017.1390474
Yeoh E, Lim BK, Fun S, et al. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients. Nephrology (Carlton). 2018;23(3):264-268. doi:10.1111/nep.12978
Bukara-Radujković G, Zdravković D, Lakić S. Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial. Vojnosanit Pregl. 2011;68(8):650-654. doi:10.2298/vsp1108650b
Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics. 2001;107(2):222-226. doi:10.1542/peds.107.2.222
Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003;26(4):1153-1157. doi:10.2337/diacare.26.4.1153
Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2006;114(2):63-67. doi:10.1055/s-2006-923887
Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes. 2006;7(3):159-164. doi:10.1111/j.1399-543X.2006.00162.x
Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5 Pt 1):933-938. doi:10.1542/peds.111.5.933
Raviteja KV, Kumar R, Dayal D, Sachdeva N. Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: an open-label randomized control trial. Sci Rep. 2019;9(1):6120. doi:10.1038/s41598-019-42555-6
Yates K, Hasnat Milton A, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care. 2006;29(7):1512-1517. doi:10.2337/dc05-2315
Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA. 2017;317(4):379-387. doi:10.1001/jama.2016.19976
Lind M, Odén A, Fahlén M, Eliasson B. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia. 2010;53(6):1093-1098. doi:10.1007/s00125-010-1706-z
Lind M, Odén A, Fahlén M, Eliasson B. A systematic review of HbA1c variables used in the study of diabetic complications. Diabetes Metab Syndr Clin Res Rev. 2008;2(4):282-293.
United States Deprtment of Health and Human Services FaDA, Center for Drug Evaluation and Research Guidance for Industry. Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention. Accessed 30 Dec 2022, https://www.regulations.gov/document/FDA-2008-D-0118-0003
Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab. 2014;16(3):193-205. doi:10.1111/dom.12129
Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol. 2021;58(4):401-410. doi:10.1007/s00592-020-01589-3
Maiorino MI, Signoriello S, Maio A, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156. doi:10.2337/dc19-1459
Ajjan RA, Abougila K, Bellary S, et al. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients. Diab Vasc Dis Res. 2016;13(3):211-219. doi:10.1177/1479164115624680
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the Management of Insulin-Treated Type 2 Diabetes: a multicenter open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55-73. doi:10.1007/s13300-016-0223-6
Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. doi:10.2337/dci19-0028
Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986. doi:10.1056/NEJM199309303291401
Karter A, Ackerson L, Darbinian J, et al. Self-monitoring of blood glucose levels and glycemic control: the northern California Kaiser Permanente diabetes registry. Am J Med. 2001;11(1):1-9. doi:10.1016/s0002-9343(01)00742-2
Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials. J Diabetes Sci Technol. 2018;12(1):183-189. doi:10.1177/1932296817719290
Di Molfetta S, Bosi E, Ceriello A, et al. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: a novel analysis of data from the PRISMA trial. Diabetes Res Clin Pract. 2021;181:109070. doi:10.1016/j.diabres.2021.109070
Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Res Clin Pract. 2012;97(1):6-15. doi:10.1016/j.diabres.2012.03.002
Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384
Edelman S, Bruttomesso D, Close KL, et al. 851-P: technology use by age and region in adults with type 1 diabetes (T1D) in the SAGE study. Diabetes. 2020;69:851-P.
Pitocco D, Laurenzi A, Tomaselli L, et al. Health care organization and use of technological devices in people with diabetes in Italy: results from a survey of the working group on diabetes and technology. Nutr Metab Cardiovasc Dis. 2022;32:2392-2398. doi:10.1016/j.numecd.2022.07.003
Isaacs D, Bellini NJ, Biba U, Cai A, Close KL. Health care disparities in use of continuous glucose monitoring. Diabetes Technol Ther. 2021;23(S3):S81-S87. doi:10.1089/dia.2021.0268